CORBUS PHARMACEUTICALS HLDGS (CRBPXXXX)
Institutional ownership reported to the SEC as of Q1 2023, across 18 quarters.
1
Reporting holders
$595
Reported value
0.0%
Held as options
-46
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $595 | 100 | 0.00% | 7q | -75.0%-$1.8K |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2023 | 1 | $595 | 100 | 0 | 0 | 1 | 0.0% |
| Q4 2022 | 47 | $1.1M | 10,182,152 | 13 | 5 | 8 | 1.4% |
| Q3 2022 | 57 | $3.9M | 23,446,433 | 8 | 8 | 14 | 1.5% |
| Q2 2022 | 61 | $8.1M | 31,837,124 | 10 | 11 | 17 | 1.4% |
| Q1 2022 | 64 | $22.0M | 41,222,554 | 7 | 14 | 22 | 1.3% |
| Q4 2021 | 72 | $28.7M | 45,818,840 | 11 | 22 | 18 | 2.3% |
| Q3 2021 | 83 | $46.5M | 44,799,065 | 9 | 20 | 26 | 1.9% |
| Q2 2021 | 96 | $93.2M | 49,629,255 | 15 | 20 | 32 | 2.4% |
| Q1 2021 | 108 | $92.4M | 44,000,981 | 17 | 35 | 23 | 4.3% |
| Q4 2020 | 105 | $54.4M | 40,020,517 | 15 | 22 | 40 | 4.4% |
| Q3 2020 | 125 | $123.6M | 56,463,774 | 13 | 50 | 32 | 16.3% |
| Q2 2020 | 148 | $448.1M | 45,656,239 | 47 | 41 | 27 | 14.5% |
| Q1 2020 | 111 | $192.0M | 35,337,378 | 29 | 43 | 18 | 3.4% |
| Q4 2019 | 101 | $174.2M | 31,617,747 | 12 | 31 | 24 | 0.9% |
| Q3 2019 | 99 | $157.9M | 31,813,886 | 15 | 22 | 33 | 1.9% |
| Q2 2019 | 102 | $239.2M | 32,942,546 | 19 | 32 | 29 | 4.6% |
| Q1 2019 | 98 | $171.3M | 23,633,282 | 25 | 40 | 15 | 4.1% |
| Q4 2018 | 79 | $157.9M | 26,473,315 | 2 | 2 | 2 | 1.9% |